zirconium has been researched along with Squamous Cell Carcinoma of Head and Neck in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Azevedo, EC; Baik, FM; Castillo, J; Chin, FT; Colevas, AD; Duan, H; Ferri, V; Freeman, L; Hom, M; Iagaru, A; Kaplan, MJ; Koran, ME; Lee, YJ; Martin, BA; Raymundo, RC; Rosenthal, EL; Shen, B; Valencia, A; van den Berg, NS; Zhou, Q | 1 |
Bahce, I; de Gruijl, TD; Elgadi, M; Grempler, R; Hesse, R; Huisman, MC; Menke-van der Houven van Oordt, CW; Miedema, IHC; Peltzer, A; Pitarch, AP; Thiele, A; van Dongen, GAMS; Vugts, DJ; Zwezerijnen, GJC | 1 |
1 trial(s) available for zirconium and Squamous Cell Carcinoma of Head and Neck
Article | Year |
---|---|
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Panitumumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2022 |
1 other study(ies) available for zirconium and Squamous Cell Carcinoma of Head and Neck